Foundayo

Every GLP-1 the FDA has approved, and the active ingredient inside each one.

Definition

Orforglipron tablets from Eli Lilly, FDA-approved April 2026 as the first oral non-peptide GLP-1 receptor agonist. Taken daily on an empty stomach with a 30-minute wait. Its arrival matters commercially: a pill with no cold chain and no needle changes what a telehealth seller has to justify charging for.

How to take Foundayo (orforglipron) →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.

Other terms under Drugs and brands

Wegovy
Ozempic
Rybelsus
Saxenda
Zepbound
Mounjaro
Semaglutide
Tirzepatide
Orforglipron
Retatrutide
CagriSema
Cagrilintide
Survodutide
MariTide (Maridebart Cafraglutide)
Ecnoglutide

Where the evidence lives

How to take Foundayo (orforglipron)
The full GLP-1 glossary (149 terms, 8 categories)
Research articles — written from primary sources
Tools and calculators
Compare GLP-1 telehealth providers